Mesa Laboratories (NASDAQ:MLAB) Issues Earnings Results, Beats Estimates By $0.66 EPS

Mesa Laboratories (NASDAQ:MLAB) issued its quarterly earnings data on Tuesday. The medical instruments supplier reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.66, Zacks reports. Mesa Laboratories had a negative net margin of 107.56% and a positive return on equity of 28.52%.

Mesa Laboratories Trading Up 1.2 %

Shares of Mesa Laboratories stock opened at $138.90 on Thursday. Mesa Laboratories has a 1 year low of $83.68 and a 1 year high of $152.75. The company’s fifty day simple moving average is $133.67 and its 200-day simple moving average is $125.66. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.51 and a current ratio of 0.70.

Mesa Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, February 28th will be given a $0.16 dividend. The ex-dividend date is Friday, February 28th. This represents a $0.64 annualized dividend and a dividend yield of 0.46%. Mesa Laboratories’s dividend payout ratio is -1.40%.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, November 13th.

Mesa Laboratories Company Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.